Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Manhattan Associates
MANH
$12.1B
| $2.53M | ﹤0.01% |
42,343
-1,393
| -3% | -$77.1K |
|
|
FOE
602
DELISTED
Ferro Corporation
FOE
| $2.5M | ﹤0.01% |
+149,100
| New | +$2.16M |
|
|
CIR
603
DELISTED
CIRCOR International, Inc
CIR
| $2.48M | ﹤0.01% |
45,498
-258,909
| -85% | -$14.3M |
|
|
RVNC
604
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.48M | ﹤0.01% |
77,553
-31,814
| -29% | -$818K |
|
605
Meritage Homes
MTH
$4.78B
| $2.47M | ﹤0.01% |
105,072
+17,982
| +21% | +$406K |
|
|
INFN
606
DELISTED
Infinera Corporation Common Stock
INFN
| $2.47M | ﹤0.01% |
117,530
-6,127
| -5% | -$125K |
|
607
Lennar Class A
LEN
$20.4B
| $2.38M | ﹤0.01% |
48,938
+12,507
| +34% | +$575K |
|
608
Keurig Dr Pepper
KDP
$42.8B
| $2.36M | ﹤0.01% |
32,422
+5,169
| +19% | +$394K |
|
|
DST
609
DELISTED
DST Systems Inc.
DST
| $2.34M | ﹤0.01% |
37,186
-3,530
| -9% | -$209K |
|
|
RMP
610
DELISTED
Rice Midstream Partners LP
RMP
| $2.32M | ﹤0.01% |
133,598
| – | – |
|
611
Altria Group
MO
$125B
| $2.32M | ﹤0.01% |
47,365
+25,729
| +119% | +$1.3M |
|
|
CBAY
612
DELISTED
Cymabay Therapeutics
CBAY
| $2.31M | ﹤0.01% |
858,786
-62,369
| -7% | -$256K |
|
|
STDY
613
DELISTED
SteadyMed Ltd
STDY
| $2.29M | ﹤0.01% |
431,096
+1,143
| +0.3% | +$9.23K |
|
|
ETP
614
DELISTED
Energy Transfer Partners, L.P.
ETP
| $2.24M | ﹤0.01% |
58,936
| – | – |
|
615
L3Harris
LHX
$55.4B
| $2.17M | ﹤0.01% |
28,204
-20,188
| -42% | -$1.6M |
|
616
Enterprise Products Partners
EPD
$83.7B
| $2.16M | ﹤0.01% |
72,288
| – | – |
|
|
SFG
617
DELISTED
STANCORP FINL GRP
SFG
| $2.13M | ﹤0.01% |
28,195
-1,111
| -4% | -$81.8K |
|
618
Deere & Co
DE
$165B
| $2.09M | ﹤0.01% |
+21,490
| New | +$1.95M |
|
619
Fulton Financial
FULT
$4.68B
| $2.07M | ﹤0.01% |
158,579
-6,759
| -4% | -$85.7K |
|
|
BHI
620
DELISTED
Baker Hughes
BHI
| $2.04M | ﹤0.01% |
33,079
-6,192
| -16% | -$405K |
|
|
NVET
621
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
| $2.03M | ﹤0.01% |
410,195
-53,311
| -12% | -$369K |
|
622
Newmont
NEM
$96.2B
| $1.97M | ﹤0.01% |
84,309
-15,783
| -16% | -$395K |
|
623
ArcelorMittal
MT
$49.5B
| $1.96M | ﹤0.01% |
88,365
+5,202
| +6% | +$125K |
|
|
CTRA
624
DELISTED
Coterra Energy
CTRA
| $1.96M | ﹤0.01% |
62,040
-11,614
| -16% | -$388K |
|
|
DNB
625
DELISTED
Dun & Bradstreet
DNB
| $1.94M | ﹤0.01% |
15,869
+10,602
| +201% | +$1.36M |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.